Orchestra BioMed Inc. (OBIO)
5.55
0.28 (5.31%)
At close: Jan 15, 2025, 1:50 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -49.12M | -33.61M | -23.01M | -21.36M |
| Depreciation & Amortization | 287.00K | 222.00K | 181.00K | 137.00K |
| Stock-Based Compensation | 7.63M | 3.41M | 302.00K | 221.00K |
| Other Working Capital | -3.58M | -451.00K | 1.47M | -5.41M |
| Other Non-Cash Items | -1.61M | 4.77M | 217.00K | 2.93M |
| Deferred Income Tax | n/a | -3.63M | 288.00K | n/a |
| Change in Working Capital | -3.31M | -451.00K | 2.60M | -8.12M |
| Operating Cash Flow | -46.13M | -29.29M | -19.43M | -26.18M |
| Capital Expenditures | -78.00K | -591.00K | -274.00K | -539.00K |
| Acquisitions | n/a | -29.06M | -13.29M | -27.50M |
| Purchase of Investments | -142.03M | -63.53M | -213.00K | -15.62M |
| Sales Maturities Of Investments | 152.80M | 92.59M | 13.50M | 43.13M |
| Other Investing Acitivies | n/a | -63.53M | 13.29M | 27.50M |
| Investing Cash Flow | 10.69M | -64.12M | 13.02M | 26.97M |
| Debt Repayment | -10.85M | 3.55M | -4.00M | 10.00M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 57.06M | -10.13M | 7.00K | n/a |
| Financial Cash Flow | 46.22M | 103.26M | -3.99M | 10.00M |
| Net Cash Flow | 10.78M | 18.03M | -10.40M | 10.78M |
| Free Cash Flow | -46.20M | -29.88M | -19.70M | -26.72M |